These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 21295953

  • 1. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers.
    Andreou D, Saetre P, Kähler AK, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG.
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):700-4. PubMed ID: 21295953
    [Abstract] [Full Text] [Related]

  • 2. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers.
    Jönsson EG, Bah J, Melke J, Abou Jamra R, Schumacher J, Westberg L, Ivo R, Cichon S, Propping P, Nöthen MM, Eriksson E, Sedvall GC.
    BMC Psychiatry; 2004 Mar 04; 4():4. PubMed ID: 15102340
    [Abstract] [Full Text] [Related]

  • 3. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers.
    Jönsson EG, Nöthen MM, Gustavsson JP, Neidt H, Bunzel R, Propping P, Sedvall GC.
    Psychiatry Res; 1998 Jun 02; 79(1):1-9. PubMed ID: 9676821
    [Abstract] [Full Text] [Related]

  • 4. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M.
    Med Biol; 1985 Jun 02; 63(1):1-17. PubMed ID: 2582215
    [Abstract] [Full Text] [Related]

  • 5. A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index.
    Ducci F, Newman TK, Funt S, Brown GL, Virkkunen M, Goldman D.
    Mol Psychiatry; 2006 Sep 02; 11(9):858-66. PubMed ID: 16770335
    [Abstract] [Full Text] [Related]

  • 6. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid.
    Rogers J, Martin LJ, Comuzzie AG, Mann JJ, Manuck SB, Leland M, Kaplan JR.
    Biol Psychiatry; 2004 Apr 01; 55(7):739-44. PubMed ID: 15039003
    [Abstract] [Full Text] [Related]

  • 7. Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis.
    Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG.
    Psychiatry Res; 2015 Sep 30; 229(1-2):497-504. PubMed ID: 26142836
    [Abstract] [Full Text] [Related]

  • 8. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.
    Biol Psychiatry; 1983 Oct 30; 18(10):1141-52. PubMed ID: 6197099
    [Abstract] [Full Text] [Related]

  • 9. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A, García JC, Fernández R, Fernández Cartaya L.
    Bol Estud Med Biol; 1993 Oct 30; 41(1-4):13-9. PubMed ID: 7521168
    [Abstract] [Full Text] [Related]

  • 10. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K.
    No To Shinkei; 1982 Nov 30; 34(11):1099-106. PubMed ID: 6186264
    [Abstract] [Full Text] [Related]

  • 11. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J, Söderman E, Andreou D, Sedvall GC, Agartz I, Jönsson EG.
    Psychiatry Res; 2018 May 30; 263():30-34. PubMed ID: 29482043
    [Abstract] [Full Text] [Related]

  • 12. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T, Eriksson M, Sjöberg S, Nordin C.
    J Psychiatr Res; 1996 May 30; 30(3):201-8. PubMed ID: 8884658
    [Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK, Nordin C, Jönsson EG, Engberg G, Linderholm KR, Erhardt S.
    J Psychiatr Res; 2007 May 30; 41(1-2):144-51. PubMed ID: 16434056
    [Abstract] [Full Text] [Related]

  • 14. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome.
    Kay AD, Schapiro MB, Riker AK, Haxby JV, Rapoport SI, Cutler NR.
    Ann Neurol; 1987 Apr 30; 21(4):408-11. PubMed ID: 2437853
    [Abstract] [Full Text] [Related]

  • 15. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH.
    Biol Psychiatry; 2004 Sep 15; 56(6):418-26. PubMed ID: 15364040
    [Abstract] [Full Text] [Related]

  • 16. Tryptophan hydroxylase gene 1 (TPH1) variants associated with cerebrospinal fluid 5-hydroxyindole acetic acid and homovanillic acid concentrations in healthy volunteers.
    Andreou D, Saetre P, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG.
    Psychiatry Res; 2010 Dec 30; 180(2-3):63-7. PubMed ID: 20580984
    [Abstract] [Full Text] [Related]

  • 17. HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses.
    Lappalainen J, Long JC, Virkkunen M, Ozaki N, Goldman D, Linnoila M.
    Biol Psychiatry; 1999 Sep 15; 46(6):821-6. PubMed ID: 10494451
    [Abstract] [Full Text] [Related]

  • 18. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul 15; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]

  • 19. Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers.
    Jönsson EG, Saetre P, Edman-Ahlbom B, Sillén A, Gunnar A, Andreou D, Agartz I, Sedvall G, Hall H, Terenius L.
    J Neural Transm (Vienna); 2008 Dec 15; 115(12):1695-9. PubMed ID: 18781277
    [Abstract] [Full Text] [Related]

  • 20. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ, Koslow SH, Seifert WE, Caprioli RM, Singer HS.
    Ann Neurol; 1979 Jul 15; 6(1):37-9. PubMed ID: 292354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.